gerodolan 10 mg/ml injektions-/infusionsvätska, lösning
gerodolan 2 mg/ml injektions-/infusionsvätska, lösning
gerodolan 50 mg/ml injektions-/infusionsvätska, lösning
hydofon 10 mg/ml injektions-/infusionsvätska, lösning
hydofon 20 mg/ml injektions-/infusionsvätska, lösning
hydofon 50 mg/ml injektions-/infusionsvätska, lösning
hydofon 2 mg/ml injektions-/infusionsvätska, lösning
intrinsa
warner chilcott uk ltd. - testosterone - sexual dysfunctions, psychological - sex hormones and modulators of the genital system, - intrinsa is indicated for the treatment of hypoactive sexual desire disorder (hsdd) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.
livensa
warner chilcott deutschland gmbh - testosterone - sexual dysfunctions, psychological - sex hormones and modulators of the genital system, - livensa is indicated for the treatment of hypoactive sexual desire disorder (hsdd) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.
midazolam viatris
viatris limited - midazolam 1 mg/ml; - solution for injection - 1 mg/ml - active: midazolam 1 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).